Skip to main content
. 2022 Mar 8;17(3):e0264123. doi: 10.1371/journal.pone.0264123

Table 2. Disease modifying therapies efficacy and discontinuation.

DMT ARR* CDP-6 months* Discontinuation§ Reference
RR 95%CI HR 95%CI HR 95%CI 12
Interferon beta 0.65 0.48–0.88 0.93 0.71–1.20 -
Siponimod 0.59 0.35–0.99 0.50 0.35–0.74 0.87 0.64–1.18

ARR = annual relapse rate; CDP = confirmed disability progression; HR = Hazard ratio; RR = relative risk; SE Standard error.

* Drug compared with placebo; § Siponimod versus interferon beta 1b.